BioSpace News Archive

Tenaya Therapeutics, Inc. announced that it will present new preclinical data on its novel AAV capsids for cardiac gene delivery at the 29th Annual Congress of the European Society of Gene and Cell Therapy, October 11 - 14, 2022 in Edinburgh, Scotland.

Freeline Therapeutics Holdings plc announced that the first patient has been dosed in the second dose cohort of the Phase 1/2 MARVEL-1 clinical trial of FLT190 in Fabry disease, a debilitating inherited disorder that leads to progressive organ damage and can result in early death as a result of a harmful build-up of fat in cells due to an enzyme deficiency.

CytoSorbents Corporation announces that Dr. Phillip Chan, Chief Executive Officer, will present at the Dawson James Securities 2022 Small Cap Growth Conference on Wednesday, October 12th, 2022. Company management will also meet with investors in 1x1 meetings throughout the conference.

Lumen Bioscience today announced the publication of data demonstrating a needle-free, spirulina-produced recombinant vaccine that protects against malaria.

Fewer participants treated with SNG001 compared to placebo progressed to hospitalisation (1/110 vs 7/110, P=0.07).